A multi-analyte panel for non-invasive pharmacokinetic monitoring of second-line anti-tuberculosis drugs

Int J Tuberc Lung Dis. 2016 Jul;20(7):991-2. doi: 10.5588/ijtld.16.0201.

Authors

Roy Gerona¹, Anita Wen¹, Catherine Koss², Peter Bacchetti³, Monica Gandhi², John Metcalfe⁴

Affiliations

¹ Maternal-Fetal Medicine Division, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco (UCSF), USA.
² Division of HIV, Infectious Diseases and Global Medicine, Department of Medicine, UCSF, USA.
³ Department of Epidemiology and Biostatistics, UCSF, USA.
⁴ Curry International Tuberculosis Center, Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, UCSF, California, USA. [email protected].

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural

MeSH terms

Antitubercular Agents / administration & dosage
Antitubercular Agents / blood
Antitubercular Agents / pharmacokinetics*
Chromatography, Liquid
Drug Monitoring / methods*
Drug Resistance, Multiple, Bacterial*
Humans
Predictive Value of Tests
Reproducibility of Results
Spectrometry, Mass, Electrospray Ionization
Tandem Mass Spectrometry
Tuberculosis, Multidrug-Resistant / blood
Tuberculosis, Multidrug-Resistant / diagnosis
Tuberculosis, Multidrug-Resistant / drug therapy*
Tuberculosis, Multidrug-Resistant / microbiology

Substances

Antitubercular Agents

Grants and funding